← Back to Analyst Consensus 
FTH Buy
Faeth Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Sep 16, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Sep 14, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 32% |
| Sep 9, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Aug 21, 2026 | Needham | initiate | — → Buy | — | 50% |
| Aug 11, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 4, 2026 | Jones Trading | initiate | — → Buy | — | 50% |
| Jul 31, 2026 | Raymond James | initiate | — → Outperform | — | 54% |
| Jul 28, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Jul 20, 2026 | Citizens | initiate | — → Market Outperform | — | 47% |
| Jul 16, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 26, 2026 | Baird | initiate | — → Outperform | — | 55% |
| Jun 22, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| Jun 15, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 11, 2026 | BTIG | initiate | — → Buy | — | 52% |
| May 29, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| May 28, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 32% |
| May 22, 2026 | Citigroup | initiate | — → Buy | — | 54% |
Price Target Trend
Jun 19, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days